In a recent study presented at the International Gynecologic Cancer Society’s annual meeting, trastuzumab deruxtecan (T-DXd), an antibody-drug conjugate, demonstrated highly encouraging response rates in patients with HER2-expressing gynecologic cancers. Dr. Ritu Salani of the University of California Los Angeles discusses the findings from the DESTINY-PanTumor02 trial and explains why they have the potential to
0 Comments
The Bank of England recently released its half-yearly Financial Stability Report, providing insights into the current state of the economy. While household finances are performing better than expected, the report highlights the lingering impact of higher borrowing costs that have yet to fully affect the overall economy. In this article, we will delve into the
0 Comments
A pregnant woman in Aberfan, South Wales, was the victim of a brutal “targeted attack” that shocked the local community. The incident occurred in broad daylight on Moy Road, and the victim, a 29-year-old woman, was immediately rushed to the hospital. Although her injuries are not believed to be life-threatening, the sense of shock reverberated
0 Comments
The recent court appearance of retired American diplomat, Victor Manuel Rocha, has sent shockwaves throughout the United States. Rocha, a former U.S. ambassador to Bolivia during the Clinton administration, is accused of spending over four decades as a spy for Cuba. This espionage case, dubbed as “one of the highest-reaching and longest-lasting infiltrations of the
0 Comments